Cargando…
Correlated Transcriptional Responses Provide Insights into the Synergy Mechanisms of the Furazolidone, Vancomycin, and Sodium Deoxycholate Triple Combination in Escherichia coli
Effective therapeutic options are urgently needed to tackle antibiotic resistance. Furazolidone (FZ), vancomycin (VAN), and sodium deoxycholate (DOC) show promise as their combination can synergistically inhibit the growth of, and kill, multidrug-resistant Gram-negative bacteria that are classified...
Autores principales: | Olivera, Catrina, Cox, Murray P., Rowlands, Gareth J., Rakonjac, Jasna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550143/ https://www.ncbi.nlm.nih.gov/pubmed/34494879 http://dx.doi.org/10.1128/mSphere.00627-21 |
Ejemplares similares
-
In vitro synergy between sodium deoxycholate and furazolidone against enterobacteria
por: Le, Vuong Van Hung, et al.
Publicado: (2020) -
In vitro synergy of 5-nitrofurans, vancomycin and sodium deoxycholate against Gram-negative pathogens
por: Olivera, Catrina, et al.
Publicado: (2021) -
When less is more: shortening the Lpp protein leads to increased vancomycin resistance in Escherichia coli
por: Wykes, Hannah, et al.
Publicado: (2023) -
Complete Genome Assembly of a Multidrug-Resistant New Delhi Metallo-β-Lactamase 1 (NDM-1)-Producing Escherichia coli Human Isolate from a New Zealand Hospital
por: Olivera, Catrina, et al.
Publicado: (2020) -
Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015)